Description
Lornocare-P8 Tablets are a combination formulation containing Lornoxicam and Paracetamol, designed to provide effective relief from pain and inflammation. Lornoxicam belongs to the class of non-steroidal anti-inflammatory drugs (NSAIDs), while Paracetamol is a widely used analgesic and antipyretic agent.
Lornoxicam works by inhibiting the production of prostaglandins, which are chemicals in the body responsible for pain, inflammation, and swelling. By reducing prostaglandin synthesis, it helps relieve inflammatory pain and improve mobility in patients suffering from musculoskeletal conditions.
Paracetamol acts centrally in the brain to reduce pain and fever. When combined with Lornoxicam, it enhances the overall analgesic effect, providing faster and more effective relief from moderate to severe pain.
This combination is commonly used for the management of musculoskeletal pain, joint pain, post-operative pain, dental pain, and inflammatory conditions. The film-coated tablets are designed for convenient administration and should be taken as directed by a qualified healthcare professional.
Indications
Lornocare-P8 Tablets are indicated for the management of:
-
Musculoskeletal pain
-
Joint pain and inflammation
-
Osteoarthritis and rheumatoid arthritis
- Post-operative pain
- Dental pain
- Acute inflammatory conditions
Dosage and Administration
Lornocare-P8 Tablets should be administered only under the supervision of a qualified healthcare professional.
-
Dosage should be taken as prescribed by a healthcare professional.
-
Tablets should be swallowed whole with water, preferably after meals to minimize gastric irritation.
-
Do not exceed the recommended dosage without medical advice.
Safety Information
-
For prescription use only.
-
Use under the supervision of a qualified medical practitioner.
-
Patients with liver, kidney, or gastrointestinal disorders should consult a physician before use.
-
Avoid use in patients with known hypersensitivity to NSAIDs or Paracetamol.
